Alnylam and Collaborators Publish Pre-clinical Study Results in Nature Medicine on ALN-AT3
April 13, 2015 at 11:01 AM EDT
Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), a leading RNAi therapeutics company, announced today the publication in Nature Medicine of ...